Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
Blood
|
October 9, 1999
Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice
F E Nicolini, T L Holyoake, J D Cashman, et al.
Bone Marrow Transplantation
|
November 16, 2004
Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency
D C Kilpatrick, K Stewart, E K Allan, et al.
Leukemia
|
February 20, 2003
Imatinib mesylate-induced molecular remission of Philadelphia chromosome-positive myelodysplastic syndrome
M W Drummond, C J Lush, M A Vickers, et al.
Leukemia
|
January 20, 2009
Nuclear entrapment of BCR-ABL by combining imatinib mesylate with leptomycin B does not eliminate CD34+ chronic myeloid leukaemia cells
E K Allan, A Hamilton, S Hatziieremia, et al.
Leukemia
|
January 28, 2005
Dysregulated expression of the major telomerase components in leukaemic stem cells
M W Drummond, S F Hoare, A Monaghan, et al.
Journal of Leukocyte Biology
|
August 10, 2006
Immature monocytes from G-CSF-mobilized peripheral blood stem cell collections carry surface-bound IL-10 and have the potential to modulate alloreactivity
A R Fraser, G Cook, I M Franklin, et al.
Blood
|
February 7, 2001
Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3
T L Holyoake, X Jiang, H G Jorgensen, et al.
Leukemia
|
July 2, 2003
Stage-specific alterations in serum levels of G-CSF in chronic myeloid leukaemia
H G Jørgensen, E K Allan, X Jiang, et al.
Journal of Hematotherapy
|
November 22, 1997
CD34+ cells can be selected efficiently from cryopreserved peripheral blood progenitor cells and can retain their proliferative potential
M J Alcorn, T L Holyoake, L J Richmond, et al.
Cytotherapy
|
December 11, 2002
CML leukapheresis products can be enriched for CD34+ cells and simultaneously depleted of CD15+ cells using a simple Ab cocktail
L J Richmond, M J Alcorn, C Pearson, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
Blood
|
October 9, 1999
Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice
F E Nicolini, T L Holyoake, J D Cashman, et al.
Bone Marrow Transplantation
|
November 16, 2004
Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency
D C Kilpatrick, K Stewart, E K Allan, et al.
Leukemia
|
February 20, 2003
Imatinib mesylate-induced molecular remission of Philadelphia chromosome-positive myelodysplastic syndrome
M W Drummond, C J Lush, M A Vickers, et al.
Leukemia
|
January 20, 2009
Nuclear entrapment of BCR-ABL by combining imatinib mesylate with leptomycin B does not eliminate CD34+ chronic myeloid leukaemia cells
E K Allan, A Hamilton, S Hatziieremia, et al.
Leukemia
|
January 28, 2005
Dysregulated expression of the major telomerase components in leukaemic stem cells
M W Drummond, S F Hoare, A Monaghan, et al.
Journal of Leukocyte Biology
|
August 10, 2006
Immature monocytes from G-CSF-mobilized peripheral blood stem cell collections carry surface-bound IL-10 and have the potential to modulate alloreactivity
A R Fraser, G Cook, I M Franklin, et al.
Blood
|
February 7, 2001
Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3
T L Holyoake, X Jiang, H G Jorgensen, et al.
Leukemia
|
July 2, 2003
Stage-specific alterations in serum levels of G-CSF in chronic myeloid leukaemia
H G Jørgensen, E K Allan, X Jiang, et al.
Journal of Hematotherapy
|
November 22, 1997
CD34+ cells can be selected efficiently from cryopreserved peripheral blood progenitor cells and can retain their proliferative potential
M J Alcorn, T L Holyoake, L J Richmond, et al.
Cytotherapy
|
December 11, 2002
CML leukapheresis products can be enriched for CD34+ cells and simultaneously depleted of CD15+ cells using a simple Ab cocktail
L J Richmond, M J Alcorn, C Pearson, et al.
Page
of 7